Citation Impact
Citing Papers
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
2018 Standout
Advanced Atherosclerotic Foam Cell Formation Has Features of an Acquired Lysosomal Storage Disorder
2006
Bifluoride Ion Mediated SuFEx Trifluoromethylation of Sulfonyl Fluorides and Iminosulfur Oxydifluorides
2019 StandoutNobel
Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study
2018
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2007
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
2016 Standout
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
2020 Standout
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
2006 Standout
Universal Definition of Myocardial Infarction
2007 Standout
Plasma Myeloperoxidase Levels in Patients With Chronic Heart Failure
2006
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Effects of Torcetrapib in Patients at High Risk for Coronary Events
2007 Standout
Role of acute infection in triggering acute coronary syndromes
2010
Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure
2006
Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids
2005
High-Density Lipoprotein as a Therapeutic Target
2007
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes
2007
Macrophages in the Pathogenesis of Atherosclerosis
2011 Standout
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Utilization of Cardiac Biomarker Testing in Heart Failure
2007
Impact of the troponin standard on the prevalence of acute myocardial infarction
2003
C-Reactive Protein and Risk of Cardiovascular Disease in Men and Women From the Framingham Heart Study
2005
Cholesteryl Ester Transfer Protein Inhibitors in the Treatment of Dyslipidemia: A Systematic Review and Meta-Analysis
2013
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
2009 Standout
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
2015 Standout
The changing landscape of atherosclerosis
2021 StandoutNature
A Fluorescent Probe for the Detection of Myeloperoxidase Activity in Atherosclerosis-Associated Macrophages
2007
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
2009 StandoutNature
Magnetic nanoparticle biosensors
2010
Future Therapeutic Directions in Reverse Cholesterol Transport
2010
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Major Lipids, Apolipoproteins, and Risk of Vascular Disease
2009 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Platelet Activation and Atherothrombosis
2007 Standout
Protein carbamylation links inflammation, smoking, uremia and atherogenesis
2007
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Myeloperoxidase and its contributory role in inflammatory vascular disease
2006
The year in atherothrombosis
2004
Type 2 diabetes
2017 Standout
Update on strategies to increase HDL quantity and function
2009
Contribution of Myeloperoxidase to Smoking-dependent Vascular Inflammation
2008
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
2012
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
2015 Standout
Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials
2007
New Therapies for Reducing Low-Density Lipoprotein Cholesterol
2014
Bioluminescence imaging of myeloperoxidase activity in vivo
2009
Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases
2018 Standout
Incremental Value of Copeptin for Rapid Rule Out of Acute Myocardial Infarction
2009
Reactive oxygen species in cardiovascular disease
2011
Antimicrobial reactive oxygen and nitrogen species: concepts and controversies
2004 Standout
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Troponin T Levels in Patients with Acute Coronary Syndromes, with or without Renal Dysfunction
2002
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008 Standout
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
2011 Standout
C-Reactive Protein and Other Emerging Blood Biomarkers to Optimize Risk Stratification of Vulnerable Patients
2006
Risk of Myocardial Infarction and Stroke after Acute Infection or Vaccination
2004
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Drugs Targeting High-Density Lipoprotein Cholesterol for Coronary Artery Disease Management
2012
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
2013 Standout
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
2011 StandoutNature
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
2015 Standout
Biomarkers in Heart Failure
2008 Standout
Chronic Kidney Disease
2016 Standout
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
2015 Standout
Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18
2008
Comparative Impact of Multiple Biomarkers and N-Terminal Pro-Brain Natriuretic Peptide in the Context of Conventional Risk Factors for the Prediction of Recurrent Cardiovascular Events in the Heart Outcomes Prevention Evaluation (HOPE) Study
2006
Temporal shifts in clinical presentation and underlying mechanisms of atherosclerotic disease
2016
Update on the Discovery and Development of Cholesteryl Ester Transfer Protein Inhibitors for Reducing Residual Cardiovascular Risk
2013
Reactive Oxygen Species
2004
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Mendelian randomisation applied to drug development in cardiovascular disease: a review
2014
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves
2009 StandoutNobel
Role of Troponin in Patients With Chronic Kidney Disease and Suspected Acute Coronary Syndrome
2014
Established and Emerging Plasma Biomarkers in the Prediction of First Atherothrombotic Events
2004
National Academy of Clinical Biochemistry Standards of Laboratory Practice: Recommendations for the Use of Cardiac Markers in Coronary Artery Diseases
1999
K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients
2005
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Albumin mediates the transcytosis of myeloperoxidase by means of caveolae in endothelial cells
2004
Nitric oxide, oxidants, and protein tyrosine nitration
2004
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Mechanisms of Activation of NADPH Oxidases
2004
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Development of a Hydrogenative Reductive Amination for the Synthesis of Evacetrapib: Unexpected Benefits of Water
2014
2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2011
Biomarkers of Cardiovascular Disease
2006
Design Strategies for Water-Soluble Small Molecular Chromogenic and Fluorogenic Probes
2013 Standout
Serum Myeloperoxidase Levels Independently Predict Endothelial Dysfunction in Humans
2004
Antiinflammatory Properties of HDL
2004 Standout
Myeloperoxidase: friend and foe
2005 Standout
Weekend versus Weekday Admission and Mortality from Myocardial Infarction
2007 Standout
Treatment of Periodontitis and Endothelial Function
2007 Standout
2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2013
Works of Ellen McErlean being referenced
The Vulnerable Coronary Plaque
2000
Peroxisome proliferator–activated receptor γ agonists for the Prevention of Adverse events following percutaneous coronary Revascularization—results of the PPAR Study
2007
Troponin t in elders with suspected acute coronary syndromes
2003
Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol
2011
Risk stratification for patients undergoing nonurgent percutaneous coronary intervention using N-terminal pro–B-type natriuretic peptide: A Clopidogrel for the Reduction of Events During Observation (CREDO) substudy
2006
Comparison of troponin T versus creatine kinase-MB in suspected acute coronary syndromes
2000
Ability of troponins to predict adverse outcomes in patients with renal insufficiency and suspected acute coronary syndromes: a case-matched study
1999
Prognostic Value of Myeloperoxidase in Patients with Chest Pain
2003
Effects of a Potent and Selective PPAR-α Agonist in Patients With Atherogenic Dyslipidemia or Hypercholesterolemia
2007
Prognostic Value of Myeloperoxidase in Patients With Chest Pain
2004